|
|
1 |
Aripiprazole |
1,900 |
1% |
2 |
Rabeprazole |
2,729 |
-4% |
3 |
Fentanyl |
578 |
40% |
4 |
Risedronate |
1,619 |
-4% |
5 |
Pioglitazone |
2,880 |
25% |
6 |
Nifedipine |
825 |
0% |
7 |
Amphetamine |
864 |
18% |
8 |
Fluticasone +
Salmeterol |
6,129 |
12% |
9 |
Pemetrexed |
612 |
32% |
10 |
Fexofenadine |
864 |
-49% |
11 |
Ramipril |
653 |
18% |
12 |
Glimepiride |
567 |
-33% |
13 |
Zolpidem |
2,545 |
33% |
14 |
Amlodipine |
506 |
4% |
15 |
Darbepoetin alfa |
4,121 |
26% |
16 |
Donepezil |
2,519 |
24% |
18 |
Anastrozole |
1,508 |
28% |
19 |
Candesartan |
1,768 |
8% |
20 |
Co-amoxiclav |
1,055 |
-13% |
21 |
Rosiglitazone |
3,043 |
26% |
22 |
Irbesartan |
2,372 |
13% |
23 |
Bevacizumab |
2,364 |
78% |
24 |
Moxifloxacin |
822 |
17% |
25 |
Interferon beta-1a |
1,707 |
11% |
26 |
Voglibose |
476 |
-13% |
27 |
Olmesartan |
1,370 |
73% |
28 |
Interferon beta-1b |
1,245 |
14% |
29 |
Clarithromycin |
816 |
-23% |
30 |
Ibandronate |
565 |
454% |
31 |
Botulin toxin |
982 |
18% |
32 |
Aripiprazole |
Sales 2006 (USD millions) |
Change from 2005 |
33 |
Exenatide |
649 |
464% |
34 |
Irinotecan |
903 |
-1% |
35 |
Caspofungin |
530 |
-7% |
36 |
Doxazosin |
538 |
-8% |
37 |
Bicalutamide |
1,206 |
7% |
38 |
Celecoxib |
2,039 |
18% |
39 |
Mycophenolate mofetil |
1,470 |
8% |
40 |
Imiglucerase |
1,007 |
8% |
41 |
Tadalafil |
971 |
30% |
42 |
Ciprofloxacin |
755 |
-6% |
43 |
Desloratadine |
722 |
12% |
44 |
Loratadine |
418 |
-5% |
45 |
Ipratropium + Salbutamol |
843 |
20% |
46 |
Lamivudine + Zidovudine |
977 |
-8% |
47 |
Methylphenidate |
930 |
20% |
48 |
Bisoprolol |
455 |
4% |
49 |
Glatiramer |
2,757 |
19% |
50 |
Carvedilol |
1,441 |
38% |
<< Previous 1 | 2 | 3 | 4 | Next >> |
|